Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.00 | N/A |
| PEG Ratio (TTM) | 0.01 | N/A |
| P/S Ratio (TTM) | 2.21 | N/A |
| P/B Ratio (TTM) | 0.79 | N/A |
| P/FCF Ratio (TTM) | 10.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.57 | N/A |
| Price to 5YR AVG FCF Ratio | 6.76 | N/A |
Profitability (33%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.52% | N/A |
| ROE (TTM) | 8.88% | N/A |
| Net Profit Margin (TTM) | 24.50% | N/A |
| ROIC 5YR AVG | 0.40% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 81.29% | 27.23% | -7.51% |
| Revenue | 118.44% | 29.52% | 46.06% |
| Net Income | 79.93% | 45.12% | 18.70% |
| Cash Flow | 143.14% | -16.72% | -13.75% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.19 | N/A |
| Quick Ratio (TTM) | 6.19 | N/A |
| D/E Ratio (TTM) | 14.57 | N/A |
| Interest Coverage (TTM) | 3.00 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.09 | N/A |
| LTL to 5YR AVG FCF | 158.30 | N/A |
| Shares Outstanding Growth 5YR AVG | 34.10% | N/A |